Senior Management Team
Clive Seymour, BSc (Hons), Dip Mgmt
Chief Executive Officer
Clive Seymour has extensive global commercial experience in the life sciences and analytical instrumentation sectors, bringing to the Board particular skills in business transformation, operations management, business planning and global marketing and sales. He is a co-founder and consultant at Life Science New Zealand, CEO of Lifeonics Limited and co-owns Science Directions Ltd. He previously held global VP and EVP roles at Pharmacia Biotech, Biacore AB (both now GE owned) and Bruker Corporation.
Mrs Jenny Douglas, BSc, MPhil
Jenny looks after plant processes and capacity with a view to optimising the manufacturing processes, equipment, material, and human resources. From Scotland originally, Jenny worked as an engineer at Motorola before moving to Christchurch in 1999. She held engineering and management roles before returning to her “chemistry roots” joining Canterbury Scientific in 2012.
Dr Antony Mathews
Head of Research and Development
Tony brings 30 years of US based experience in academic and biotechnology settings in protein chemistry and chemical modification, haemoglobin biophysical chemistry, haemoglobin based blood substitutes, formulation, and protein purification process development. He has numerous publications and patents in haemoglobin structure-function relationships and the design and purification of haemoglobin based blood substitutes.
Mrs Fiona Gurevin, BCom, ACA
Financial Controller and Commercial Operations
A long standing member of the company, Fiona, an associate chartered accountant with extensive experience in corporate accounting, is responsible for the management of Canterbury Scientific’s financial group. Working with the CEO, Fiona also manages commercial operations and business relationships ensuring the company remains focused on the needs of our customers.
Mr John Barr, BSc, FNZIM, MInstD
Chairman of the Board
John is a professional director and is the Chairman and/or Independent Director for a range of companies. Additionally, his focus is providing governance and business advice at Managing Director/Owner level primarily for SMEs. Other roles include the St George’s Hospital Society President and Board member and a member of the GlobalScots Scottish business support network.
John has chief executive and directorship experience across a broad range of industry environments, covering manufacturing, contract manufacturing, technology, service sectors and electricity company trusts. Directorship and governance roles began in 1990. He is a past National President of the NZ Organisation for Quality.
Mr Bryce Hawkins, CA, IIA.
Deputy Chairman of the Board, Founder shareholder
Bryce is a business consultant and Chartered Accountant with extensive experience in corporate development and management. For a number of years he was a senior consultant with Price Waterhouse where he specialised in corporate recovery and development.
Dr Maurice Owen, BSc(Hons), PhD, BD, FACB
Maurice worked with Robin Carrell in Clinical Biochemistry at Christchurch, New Zealand, and for a period at the University of Cambridge, England. He has published in the fields of hemoglobin, α1-antitrypsin and antithrombin-3 with a focus on the molecular pathology of variants. He has extensive experience in protein purification and stabilisation methods and a broad knowledge of large scale lyophilisation of proteins, and quality control materials.
Mr Ed Carrell, BSc (Econ) LSE
Ed is Chief Operating Officer of Global Business Solutions at Barclays in the UK with responsibility for delivery of critical services, infrastructure and payment solutions to Europe’s largest retailers and corporates.
Prior to joining Barclays he spent 9 years at Citigroup with a mixture of Sales, Product Development and Management and Operations roles and 5 years in the Armed Forces. Ed was educated in Christchurch NZ, Cambridge and London.
Dr Robert Feldman, PhD
Dr Robert Feldman is an expert in life science commercialisation and brings to the Board a combination of skills, knowledge and experiences in the sector. He is a qualified medical practitioner with a Ph.D. in Immunology and has strong commercial, global business development and governance experience. He runs Line 5 Consulting and previous worked at Pacific Channel Ltd, Somnaceutics Ltd, Imperial Innovations and Imperial College London.